Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JCO Oncology Practice is Scopus-indexed (Q1, CiteScore 6.4), WoS SCIE. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2688-1527Verify ISSN ↗2688-1535Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology (nursing) | 2 / 24 | 93rd | Q1 |
| Health Policy | 43 / 330 | 87th | Q1 |
| Oncology | 97 / 428 | 77th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 6.4.
JCO Oncology Practice is Q1 in Oncology (nursing) (rank 2 of 24), Q1 in Health Policy (rank 43 of 330) and Q1 in Oncology (rank 97 of 428), by CiteScore 2025.
JCO Oncology Practice is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.4, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.985, quartile Q1, with an H-index of 91.
JCO Oncology Practice is published by Lippincott Williams and Wilkins. Its print ISSN is 2688-1527 and its online ISSN is 2688-1535.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
JCO Oncology Practice has an h-index of 62 and a 2-year mean of 1.85 citations per paper (OpenAlex). Its Scopus CiteScore is 6.4, quartile Q1. On 2-year citations it ranks #10 of 24 Scopus journals in Oncology (nursing).
JCO Oncology Practice published 983 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from United States (88.5%), Canada (2.9%) and United Kingdom (1.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.